ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

Public Forum On NRSA Tuition Policies

April 14, 1995

In Brief: Balch To Head City of Hope; Rowinsky Moves To San Antonio; Klausner’s Deputy Joins NCI

August 9, 1996

DCT Board Okays Six Contract Recompetitions

October 23, 1987

In Congress: Bills Seek Medicare Coverage for Patients In Cancer Clinical Trials

April 23, 1999

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993